STOCK TITAN

Regional Health SEC Filings

RHEPA OTC

Welcome to our dedicated page for Regional Health SEC filings (Ticker: RHEPA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The SEC filings page for REGIONAL HEALTH PRP PFD A (RHEPA) provides access to regulatory documents filed by Regional Health Properties, Inc., the issuer of this preferred share class. Regional Health Properties, Inc. is a Georgia corporation that describes itself as a self-managed healthcare real estate investment company investing primarily in real estate purposed for senior living and long-term care. Its filings with the U.S. Securities and Exchange Commission offer detailed information on its capital structure, including preferred stock such as the series associated with RHEPA.

Regional Health Properties, Inc. submits a range of documents to the SEC. Annual reports on Form 10-K and quarterly reports on Form 10-Q describe the company’s business segments, which have included real estate services and healthcare services, and provide information on patient care revenues, rental revenues, debt obligations and preferred stock terms. Proxy statements on Schedule 14A explain governance matters such as director elections, voting rights of common and preferred shareholders, and approvals of incentive compensation plans. Current reports on Form 8-K disclose material events, including shareholder meetings, stock repurchase authorizations and merger-related developments.

Filings also detail the structure and rights of the company’s preferred stock. Disclosures describe Series A, Series B and Series D preferred shares, including that holders of Series A Preferred Stock are not entitled to vote at specified annual meetings, while holders of Series B Preferred Stock and Series D Preferred Stock elect designated directors. Other filings discuss an exchange offer in which Series A Preferred Stock may be exchanged for Series B Preferred Stock, and a stock repurchase plan authorizing purchases of Series B Preferred Stock.

For RHEPA, these documents help investors understand how the preferred shares fit within the company’s overall capital structure and governance framework. On Stock Titan, SEC filings are updated as they are made available through EDGAR, and AI-powered tools can assist in highlighting key points in lengthy reports, such as changes to preferred stock terms, board-authorized transactions affecting preferred equity, and outcomes of shareholder votes involving preferred share classes.

Rhea-AI Summary

Regional Health Properties, Inc. reported the results of its 2025 Annual Meeting of Shareholders held on January 5, 2026 in Atlanta. Common stockholders elected four directors to serve until the 2026 annual meeting, while holders of the Series B and Series D preferred stock each elected their designated directors.

Common stockholders approved the Amended and Restated 2023 Omnibus Incentive Compensation Plan and, by advisory vote, approved the compensation of the named executive officers. They expressed a preference to hold future Say‑on‑Pay votes every three years and ratified Cherry Bekaert, LLP as independent registered public accounting firm for the year ending December 31, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Regional Health Properties, Inc. filed an amended report to add a conformed signature that was accidentally left off an earlier filing and to describe the status of its 2025 Annual Meeting of Shareholders. The company convened the meeting on December 30, 2025, but there were not enough shares present or represented by proxy to reach a quorum, so no business was conducted and the meeting was adjourned.

The meeting is scheduled to reconvene at 1050 Crown Pointe Parkway, Suite 150, Atlanta, Georgia 30338, on January 5, 2026 at 1:00 a.m. Eastern Time to vote on the proposals already described in the proxy statement filed on December 10, 2025. The record date remains the close of business on November 14, 2025, and previously submitted proxies will be voted at the reconvened meeting unless properly revoked.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Regional Health Properties, Inc. reported that its 2025 Annual Meeting of Shareholders, convened on December 30, 2025 at 10:00 a.m. Eastern Time, was adjourned because there were not enough shares present or represented by proxy to constitute a quorum. No business was conducted at that session.

The meeting is scheduled to reconvene at 1050 Crown Pointe Parkway, Suite 150, Atlanta, Georgia 30338, on January 5, 2026 at 1:00 a.m. Eastern Time to vote on the proposals described in the proxy statement filed on December 10, 2025. The close of business on November 14, 2025 remains the record date for determining which shareholders may vote. Proxies already submitted will be voted at the reconvened meeting unless properly revoked, and the proposals and proxy materials remain unchanged.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Regional Health Properties, Inc. CEO, President, and Director Brent Morrison reported open-market purchases of the company’s common stock. On 12/09/2025, he bought 4,099 shares at a price of $1.45 per share, and on 12/11/2025, he bought an additional 1,950 shares at the same price. Following these transactions, he directly owns 209,499 shares of common stock. He also reports indirect beneficial ownership of 2,272 shares held through an IRA, showing both personal and retirement-account exposure to RHEP stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Regional Health Properties, Inc. is asking shareholders to vote at its 2025 Annual Meeting on board elections, pay matters and an updated equity plan. Seven directors will be elected, with different voting groups for common stock, 12.5% Series B preferred and Series D preferred holders. Common shareholders are also asked to approve an Amended and Restated 2023 Omnibus Incentive Compensation Plan, which would increase the common shares authorized for awards by 550,000, raising the total plan pool from 225,000 to 775,000 shares, including up to 775,000 incentive stock options. The proxy explains that 149,000 shares have already been issued under the 2023 plan, 117,998 shares are subject to outstanding awards and 76,000 shares remain available. Shareholders will also cast advisory votes on executive compensation, how often to hold Say‑on‑Pay, and on ratifying Cherry Bekaert as independent auditor for 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Regional Health Properties, Inc. insider Brent Morrison, who serves as CEO, President, and Director, reported an open‑market purchase of company stock. On 12/04/2025, he bought 5,403 shares of common stock at a price of $1.41 per share. After this transaction, he beneficially owns 203,450 common shares directly and an additional 2,272 shares indirectly through an IRA, increasing his personal stake in the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Regional Health Properties, Inc. reported that its Board of Directors has authorized a stock repurchase plan for up to 500,000 shares of its Series B Preferred Stock. A Special Committee of the Board will oversee the timing, size, and method of these repurchases. Shares may be bought from time to time in the open market, through privately negotiated and block transactions, and under any Rule 10b5-1 trading plan, with purchases conducted in accordance with Rule 10b-18.

The company plans to fund the repurchases using cash on hand. The program does not require Regional Health Properties to buy any specific number of shares and is expected to continue indefinitely until the 500,000-share cap is reached or the Board modifies, suspends, or terminates the program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Regional Health Properties reported Q3 2025 results reflecting its SunLink merger and expanded operations. Revenue rose to $15,138 from $4,225 a year ago, driven by patient care of $9,831, rental revenue of $1,303, and pharmacy revenue of $4,004. Net income was $3,382 versus a loss of $(982) in Q3 2024, aided by a $5,311 gain on bargain purchase.

Total assets were $72,150 and total liabilities $68,997, with stockholders’ deficit improving to $(1,538). Cash was $994 and accounts receivable $7,715. Net cash from operations for the nine months was $(994), investing provided $5,332 (including $5,975 cash acquired), and financing used $(3,818). Debt, net, was $48,578, and the company was in covenant compliance.

The SunLink merger closed on August 14, 2025, issuing 1,595,400 common shares and 1,408,121 Series D preferred shares. The Coosa and Meadowood facilities were classified as held for sale; the Coosa sale closed on November 6, 2025. The common and Series A preferred now trade on OTCQB as RHEP and RHEPA. Shares outstanding were 3,934,677 as of November 13, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Regional Health Properties (RHEP) completed the sale of its Coosa Valley Health and Rehab facility for $10.6 million. The buyer is an unaffiliated company. The company expects to record an approximately $3.7 million gain in the quarter ending December 31, 2025.

At closing, Regional repaid approximately $4.9 million of debt and received about $4.7 million in cash, after paying roughly $0.6 million of transaction expenses and depositing $0.4 million into escrow for unresolved tax liabilities tied to the facility. The company anticipates a portion of the escrow will be released back to it. Remaining proceeds will be used for general corporate and other purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Regional Health Properties filed an 8-K/A to update its disclosure following the completion of its previously announced merger with SunLink Health Systems, effective August 14, 2025. The amendment solely supplements Item 9.01.

The company filed unaudited pro forma condensed combined financial information as Exhibit 99.1 for the six months ended June 30, 2025 and for the year ended December 31, 2024. Audited and interim SunLink financial statements were not refiled because substantially the same information was previously included in the company’s Form S-4. No shell company transactions were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Regional Health (RHEPA)?

The current stock price of Regional Health (RHEPA) is $0.21 as of January 5, 2026.
Regional Health

OTC:RHEPA

RHEPA Rankings

RHEPA Stock Data

559.26k
Medical Care Facilities
Healthcare
Link
United States
Atlanta

RHEPA RSS Feed